304 related articles for article (PubMed ID: 12202770)
21. Removal of reactive oxygen species-induced 3'-blocked ends by XPF-ERCC1.
Fisher LA; Samson L; Bessho T
Chem Res Toxicol; 2011 Nov; 24(11):1876-81. PubMed ID: 22007867
[TBL] [Abstract][Full Text] [Related]
22. XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.
Lehmann J; Seebode C; Smolorz S; Schubert S; Emmert S
Cell Mol Life Sci; 2017 Jun; 74(11):2081-2094. PubMed ID: 28130555
[TBL] [Abstract][Full Text] [Related]
23. Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage.
Larminat F; Bohr VA
Nucleic Acids Res; 1994 Aug; 22(15):3005-10. PubMed ID: 8065913
[TBL] [Abstract][Full Text] [Related]
24. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
Ahmad A; Enzlin JH; Bhagwat NR; Wijgers N; Raams A; Appledoorn E; Theil AF; J Hoeijmakers JH; Vermeulen W; J Jaspers NG; Schärer OD; Niedernhofer LJ
PLoS Genet; 2010 Mar; 6(3):e1000871. PubMed ID: 20221251
[TBL] [Abstract][Full Text] [Related]
25. Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence.
Weeda G; Donker I; de Wit J; Morreau H; Janssens R; Vissers CJ; Nigg A; van Steeg H; Bootsma D; Hoeijmakers JH
Curr Biol; 1997 Jun; 7(6):427-39. PubMed ID: 9197240
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors.
Evans E; Moggs JG; Hwang JR; Egly JM; Wood RD
EMBO J; 1997 Nov; 16(21):6559-73. PubMed ID: 9351836
[TBL] [Abstract][Full Text] [Related]
27. Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex.
Bessho T; Sancar A; Thompson LH; Thelen MP
J Biol Chem; 1997 Feb; 272(6):3833-7. PubMed ID: 9013642
[TBL] [Abstract][Full Text] [Related]
28. Roles of DNA repair and reductase activity in the cytotoxicity of the hypoxia-activated dinitrobenzamide mustard PR-104A.
Gu Y; Patterson AV; Atwell GJ; Chernikova SB; Brown JM; Thompson LH; Wilson WR
Mol Cancer Ther; 2009 Jun; 8(6):1714-23. PubMed ID: 19509245
[TBL] [Abstract][Full Text] [Related]
29. Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair.
Wang X; Peterson CA; Zheng H; Nairn RS; Legerski RJ; Li L
Mol Cell Biol; 2001 Feb; 21(3):713-20. PubMed ID: 11154259
[TBL] [Abstract][Full Text] [Related]
30. ERCC1-XPF targeting to psoralen-DNA crosslinks depends on XPA and FANCD2.
Sabatella M; Pines A; Slyskova J; Vermeulen W; Lans H
Cell Mol Life Sci; 2020 May; 77(10):2005-2016. PubMed ID: 31392348
[TBL] [Abstract][Full Text] [Related]
31. Multiple DNA binding domains mediate the function of the ERCC1-XPF protein in nucleotide excision repair.
Su Y; Orelli B; Madireddy A; Niedernhofer LJ; Schärer OD
J Biol Chem; 2012 Jun; 287(26):21846-55. PubMed ID: 22547097
[TBL] [Abstract][Full Text] [Related]
32. Expression of ERCC1 antisense RNA abrogates gemicitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair.
Yang LY; Li L; Jiang H; Shen Y; Plunkett W
Clin Cancer Res; 2000 Mar; 6(3):773-81. PubMed ID: 10741696
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
Damia G; Imperatori L; Stefanini M; D'Incalci M
Int J Cancer; 1996 Jun; 66(6):779-83. PubMed ID: 8647649
[TBL] [Abstract][Full Text] [Related]
34. Molecular docking and molecular dynamics study on the effect of ERCC1 deleterious polymorphisms in ERCC1-XPF heterodimer.
Priya Doss CG; Nagasundaram N
Appl Biochem Biotechnol; 2014 Feb; 172(3):1265-81. PubMed ID: 24158589
[TBL] [Abstract][Full Text] [Related]
35. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway.
Zhang N; Liu X; Li L; Legerski R
DNA Repair (Amst); 2007 Nov; 6(11):1670-8. PubMed ID: 17669695
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3.
Lee KB; Parker RJ; Bohr V; Cornelison T; Reed E
Carcinogenesis; 1993 Oct; 14(10):2177-80. PubMed ID: 8222071
[TBL] [Abstract][Full Text] [Related]
37. Cells from ERCC1-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange but a normal frequency of homologous recombination.
Melton DW; Ketchen AM; Núñez F; Bonatti-Abbondandolo S; Abbondandolo A; Squires S; Johnson RT
J Cell Sci; 1998 Feb; 111 ( Pt 3)():395-404. PubMed ID: 9427687
[TBL] [Abstract][Full Text] [Related]
38. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
[TBL] [Abstract][Full Text] [Related]
39. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells.
Heyza JR; Arora S; Zhang H; Conner KL; Lei W; Floyd AM; Deshmukh RR; Sarver J; Trabbic CJ; Erhardt P; Chan TH; Dou QP; Patrick SM
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400270
[TBL] [Abstract][Full Text] [Related]
40. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
Bergstralh DT; Sekelsky J
Trends Genet; 2008 Feb; 24(2):70-6. PubMed ID: 18192062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]